ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months

Taiwan is ELEVAI's third Asian contract for exosomes distribution after adding the Philippines in August of 2023 and Vietnam in May 2023 Asia-Pacific represents a combined $13 Billion prestige skincare and luxury haircare market4,5Immediate access to 40 specialty hair treatment clinics and four (4) high-end medical aesthetic clinics NEWPORT BEACH, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC. (NASDAQ:ELAB) ("Elevai" or the "Company"), a medical aesthetic company specializing in physician-disp ...